A detailed history of Savant Capital, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 3,617 shares of LNTH stock, worth $323,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,617
Previous 3,527 2.55%
Holding current value
$323,830
Previous $283,000 39.93%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$77.7 - $123.62 $6,993 - $11,125
90 Added 2.55%
3,617 $396,000
Q2 2024

Aug 05, 2024

SELL
$58.87 - $83.05 $6,887 - $9,716
-117 Reduced 3.21%
3,527 $283,000
Q1 2024

May 03, 2024

BUY
$51.07 - $68.26 $186,099 - $248,739
3,644 New
3,644 $226,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.15B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.